Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. FASLODEX (fulvestrant)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

FASLODEX (fulvestrant)

Medicine - Posted on Apr 25 2019 - Updated on Jun 12 2019
Active substance (DCI)
  • fulvestrant
history (4)
  • 3/20/19

    FASLODEX (fulvestrant)

    FASLODEX (fulvestrant)
    CAV :
    54321
    icône flèche
  • 10/11/17

    FASLODEX (fulvestrant)

    Maintien du remboursement dans les mêmes conditions.
    icône flèche
  • 9/8/10

    FASLODEX (fulvestrant)

    FASLODEX (fulvestrant)
    icône flèche
  • 10/13/04

    FASLODEX 250 mg/5 ml, solution injectable (Boîte de 1 seringue pré-remplie) (code CIP : 363 490-0)

    FASLODEX 250 mg/5 ml, solution injectable (Boîte de 1 seringue pré-remplie) (code CIP : 363 490-0)
    icône flèche
Technical information
ATC code
  • L02BA03
Manufacturer
ASTRAZENECA
Presentation

FASLODEX 250 mg, solution injectable (code CIS : 63545028) 1 seringue(s) préremplie(s) en verre avec aiguille(s) de 5 ml - Code CIP : 3400936349001

All our publications
    Breast cancers Drug therapy

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
AAQgqHLnjzXqy2Bn